RT Book, Section
A1 Wang, Sunny
A2 Papadakis, Maxine A.
A2 McPhee, Stephen J.
A2 Rabow, Michael W.
A2 McQuaid, Kenneth R.
SR Print(0)
ID 1184390189
T1 Prognosis in Patients Receiving Chemotherapy
T2 Current Medical Diagnosis & Treatment 2022
YR 2022
FD 2022
PB McGraw-Hill Education
PP New York, NY
SN 9781264269389
LK accessmedicine.mhmedical.com/content.aspx?aid=1184390189
RD 2024/04/19
AB Patients  receiving  chemotherapy  for  curative  intent  will  often  tolerate  side  effects  with  the  knowledge  that  the  treatment  may  result  in  eradication  of  their  cancer.  Patients  receiving  therapy  for  palliative  intent  often  have  their  therapy  tailored  to  improve  quality  of  life  while  minimizing  major  side  effects.  A  valuable  sign  of  clinical  improvement  is  the  general  well-being  of  the  patient.  Although  general  well-being  is  a  combination  of  subjective  factors  (possibly  partly  a  placebo  effect)  and  objective  factors,  it  nonetheless  serves  as  a  sign  of  clinical  improvement  along  with  improved  appetite  and  weight  gain  and  increased  “performance  status”  (eg,  ambulatory  versus  bedridden).  Evaluation  of  factors  such  as  activity  status  enables  the  clinician  to  judge  whether  the  net  effect  of  chemotherapy  is  worthwhile  palliation  (see  Chapter  5).